David Shaw’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,000
| Closed | -$2.39M | – | 5181 |
|
|
2021
Q1 | $2.39M | Sell |
11,000
-84,200
| -88% | -$15.8M | ﹤0.01% | 2445 |
|
|
2020
Q4 | $11M | Sell |
95,200
-3,200
| -3% | -$359K | 0.01% | 1334 |
|
|
2020
Q3 | $9.58M | Hold |
98,400
| – | – | 0.01% | 1269 |
|
|
2020
Q2 | $12.1M | Buy |
98,400
+4,800
| +5% | +$545K | 0.01% | 1079 |
|
|
2020
Q1 | $8.2M | Sell |
93,600
-37,900
| -29% | -$4.01M | 0.01% | 1115 |
|
|
2019
Q4 | $13.8M | Buy |
131,500
+63,600
| +94% | +$7.13M | 0.02% | 1017 |
|
|
2019
Q3 | $7.81M | Sell |
67,900
-6,600
| -9% | -$1M | 0.01% | 1334 |
|
|
2019
Q2 | $12.8M | Buy |
74,500
+16,600
| +29% | +$2.87M | 0.02% | 998 |
|
|
2019
Q1 | $9.76M | Sell |
57,900
-21,700
| -27% | -$3.23M | 0.01% | 1121 |
|
|
2018
Q4 | $7.75M | Buy |
79,600
+34,500
| +76% | +$4.53M | 0.01% | 1247 |
|
|
2018
Q3 | $7.79M | Buy |
45,100
+21,600
| +92% | +$3.11M | 0.01% | 1265 |
|
|
2018
Q2 | $3.28M | Buy |
+23,500
| New | +$3.34M | ﹤0.01% | 1843 |
|
|
2018
Q1 | – | Sell |
-35,100
| Closed | -$4.63M | – | 3883 |
|
|
2017
Q4 | $4.63M | Hold |
35,100
| – | – | 0.01% | 1533 |
|
|
2017
Q3 | $3.56M | Buy |
35,100
+100
| +0.3% | +$10.7K | 0.01% | 1632 |
|
|
2017
Q2 | $3.51M | Buy |
35,000
+10,500
| +43% | +$1.13M | 0.01% | 1598 |
|
|
2017
Q1 | $2.96M | Sell |
24,500
-10,000
| -29% | -$1.23M | 0.01% | 1611 |
|
|
2016
Q4 | $3.85M | Buy |
34,500
+20,000
| +138% | +$2.41M | 0.01% | 1504 |
|
|
2016
Q3 | $1.93M | Buy |
+14,500
| New | +$1.39M | ﹤0.01% | 1960 |
|
|
2016
Q2 | – | Sell |
-10,000
| Closed | -$722K | – | 3610 |
|
|
2016
Q1 | $722K | Buy |
+10,000
| New | +$549K | ﹤0.01% | 2559 |
|
|
2015
Q4 | – | Sell |
-80,200
| Closed | -$7.33M | – | 4038 |
|
|
2015
Q3 | $7.33M | Sell |
80,200
-18,500
| -19% | -$2.06M | 0.01% | 1151 |
|
|
2015
Q2 | $12.1M | Buy |
98,700
+81,000
| +458% | +$9.19M | 0.02% | 908 |
|
|
2015
Q1 | $1.61M | Buy |
17,700
+7,700
| +77% | +$625K | ﹤0.01% | 2184 |
|
|
2014
Q4 | $677K | Sell |
10,000
-7,100
| -42% | -$519K | ﹤0.01% | 3113 |
|
|
2014
Q3 | $1.38M | Buy |
+17,100
| New | +$1.51M | ﹤0.01% | 2538 |
|
Other funds holding GWPH
David Shaw's GWPH Position: Q2 2021 in Review
David Shaw sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 259,796 shares — an estimated $56.4M sold.
David Shaw first reported a position in GWPH in Q2 2014 and held it in 21 quarters. The position peaked at $56.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- David Shaw reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- David Shaw sold 259,796 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $56.4M.
- David Shaw first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 21 quarters.
- David Shaw's GW Pharmaceuticals Plc American Depositary Shares position peaked at $56.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.